Sara Schlessman, CRNP

Dr. Ilana Zinn is a craniofacial orthodontist in the Johns Hopkins Medicine Department of Plastic and Reconstructive Surgery. Her areas of clinical expertise include nasoalveolar molding, interceptive orthodontics and comprehensive orthodontics for children with craniofacial anomalies. Dr. Zinn received an undergraduate degree in biology from Stern College at Yeshiva University. She earned her doctorate of medicine in dentistry from Rutgers School of Dental Medicine and a Master of Science and certificate in orthodontics and dentofacial orthopedics from the University of Detroit Mercy School of Dentistry. She completed a fellowship in cleft-craniofacial and special care orthodontics at the University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, and became a member of the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Zinn was a clinical instructor in the Division of Pediatric Dentistry at the Children’s Hospital of Pittsburgh. Dr. Zinn has served in various volunteer and teaching capacities and has received numerous awards. She is a member of the American Association of Orthodontists and the American Cleft Palate-Craniofacial Association.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA.

Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine.Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014.Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer.Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group.